language_icon
EN
HI

Artemis Medicare Services Share price

ARTEMISMED

279.8

2.38 (0.86%)
NSE
BSE
Last updated on 15 May, 2026 | 15:50 IST
Today's High

285.58

Today's Low

276.10

52 Week Low

203.35

52 Week High

297.50

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Artemis Medicare Services Chart

Artemis Medicare Services Share Key Metrics

Volume
2.07 L
Market Cap
4429.41 CR
LTQ@LTP
12@279.80
ATP
280.74
Var Margin
19.19 %
Circuit Range
221.94-332.9
Delivery %
49.24 %
Value
5.82 CR
ASM/GSM
No
Market Lot
1

Summary

Artemis Medicare Services share price is ₹279.8 as of 16 May, 2026. The stock Artemis Medicare Services intraday movement has stayed between ₹276.10 and ₹285.58, while on a 52-week basis,Artemis Medicare Services price 52 week high is ₹297.50 & its 52 week low is ₹203.35.
In terms of trading activity, Artemis Medicare Services has recorded a volume of 207358 shares, The Artemis Medicare Services has a market cap of ₹158306247 CR. The stock’s Average Traded Price (ATP) stands at ₹280.74, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 12 @ ₹279.80.
Artemis Medicare Services operates within a circuit range of ₹221.94 – ₹332.90, with a Value of ₹5.82 CR. The Delivery Percentage for the day is 49.24%. Additionally, Artemis Medicare Services currently falls under the No framework, and trades with a market lot size of 1.

Artemis Medicare Services Fundamentals

View More
P/E Ratio

42.89

P/B Ratio

5.13

Div. Yield

0.16

Sector P/E

56.28

Sector P/B

-15.69

Sec. Div. Yield

1.98

Artemis Medicare Services Resistance and Support

Pivot 277.28

Resistance

First Resistance

282.15

Second Resistance

286.87

Third Resistance

291.74

Support

First Support

272.56

Second Support

267.69

Third Support

262.97

Artemis Medicare Services Shareholding Pattern

View More
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

58.39%

Mutual Fund

1.69%

Insurance

0%

Foreign Institutional Investors

12.19%

Domestic Institutional Investors

7.36%

Retail

20.37%

Others

0%

Total Promoters
MAR '26
58.39%

Artemis Medicare Services Corporate Actions

DateAgenda
2026-05-08Audited Results & Final Dividend
2026-02-02Quarterly Results & Others
2025-11-11Quarterly Results
2025-08-05Quarterly Results
2025-05-12Audited Results & Final Dividend
2025-02-05Quarterly Results

Artemis Medicare Services News

Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Artemis Medicare Services Ltd has made the audio recording of its Q4 and FY26 earnings conference call available on its website. The call, held on May 11, 2026, discussed the operational and financial performance.
May 11 2026 15:05:00

Artemis Medicare Services Ltd - 542919 - Corporate Action-Board approves Dividend

Artemis Medicare Services Board recommended a final dividend of Re. 0.45 per equity share for FY26. This 45% dividend (Re. 1 face value) is contingent on shareholder approval at the upcoming AGM.
May 08 2026 19:05:00

Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Change in Directorate

Artemis Medicare Services Ltd. has appointed two new Independent Directors to its Board. Mr. Tapan Mitra's appointment is effective from May 8, 2026, and Dr. Girdhar J. Gyani's from August 1, 2026. Both appointments are for three-year terms and are subject to shareholder approval at the upcoming AGM.
May 08 2026 19:05:00

Artemis Medicare Services Ltd - 542919 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Artemis Medicare Services Ltd reported strong Q4 FY26 consolidated financial results. Revenue from operations increased 16.4% to Rs.279.23 crore, while net profit grew 32.1% to Rs.30.28 crore, reflecting robust performance.
May 08 2026 19:05:00

Artemis Medicare Services Ltd - 542919 - Board Meeting Outcome for Board Meeting Held On May 8, 2026

Artemis Medicare's board approved audited financial results for FY26, with Q4 consolidated net profit rising 32.1% YoY to ₹30.28 crores. They also recommended a final dividend of ₹0.45 per equity share and appointed two new independent directors.
May 08 2026 18:05:00

Artemis Medicare Services Limited

Artemis Medicare Services Ltd board will meet on May 8, 2026. The agenda includes considering audited annual financial results for the year ended March 31, 2026, and recommending a final dividend.
May 05 2026 13:05:00
Read More

About Artemis Medicare Services

NSE : 16913  
BSE : 542919  
ISIN : INE025R01021  

Artemis Medicare Services Management

NamePosition
Poonam MakkarCompany Secretary & Compliance Officer
Onkar KanwarChairman
View More

Artemis Medicare Services FAQs

The Buying Price of Artemis Medicare Services share is 279.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Artemis Medicare Services stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Artemis Medicare Services, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Artemis Medicare Services shares is 42.89. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Artemis Medicare Services shares is 5.13. Useful to assess the stock's value relative to its book value.

To assess Artemis Medicare Services’s valuation compare Sector P/E, P/B which are 56.28 & -15.69 with sector averages, along with growth rates and financial metrics.

The Market Cap of Artemis Medicare Services is 4429.41 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Artemis Medicare Services share price is 297.50 & 203.35. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Artemis Medicare Services belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost